NTAGI approves Serum Institute’s Covovax for 12-17 age group
New Delhi : The National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 year age group, sources said.India's drug regulator, the Drugs Controller General…